ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)

NCT00820079 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux

Interventions

DRUG: ADX10059
DRUG: ADX10059 Matching Placebo

Sponsor

Addex Pharma S.A.